{"id":"https://openalex.org/W2404685276","doi":null,"title":"[Perazine in the treatment of psychotic disorders--research review].","display_name":"[Perazine in the treatment of psychotic disorders--research review].","publication_year":2010,"publication_date":"2010-05-01","ids":{"openalex":"https://openalex.org/W2404685276","mag":"2404685276","pmid":"https://pubmed.ncbi.nlm.nih.gov/20672521"},"language":"pl","primary_location":{"id":"pmid:20672521","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20672521","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatria polska","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028874131","display_name":"Andrzej Kiejna","orcid":"https://orcid.org/0000-0002-3708-3853","observed_orcids":["https://orcid.org/0000-0002-3708-3853"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Andrzej Kiejna","raw_affiliation_strings":["Katedra i Klinika Psychiatrii AM we Wroc\u0142awiu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Katedra i Klinika Psychiatrii AM we Wroc\u0142awiu","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5028874131"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"44","issue":"3","first_page":"427","last_page":"34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12666","display_name":"Historical Psychiatry and Medical Practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/perazine","display_name":"perazine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/chlorpromazine","display_name":"chlorpromazine","score":0.8410000205039978},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.7960000038146973},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.843999981880188},{"id":"https://openalex.org/keywords/psychosis","display_name":"psychosis","score":0.7870000004768372},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.871999979019165},{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.9599999785423279},{"id":"https://openalex.org/keywords/sedative-effects","display_name":"sedative effects","score":0.8569999933242798},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.7519999742507935},{"id":"https://openalex.org/keywords/laboratory-monitoring","display_name":"laboratory monitoring","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6218971014022827},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6194009184837341},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5603008270263672},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5241042375564575},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4573251008987427},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4146224558353424},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41176512837409973},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.33699938654899597},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07335510849952698},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010464","descriptor_name":"Perazine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:20672521","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20672521","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatria polska","raw_type":"English Abstract"},{"id":"mag:2404685276","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20672521","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2115945168","https://openalex.org/W4211261106","https://openalex.org/W26056037","https://openalex.org/W2334848871","https://openalex.org/W2410750159","https://openalex.org/W2436226476","https://openalex.org/W2051770771","https://openalex.org/W1495535098","https://openalex.org/W2153396798","https://openalex.org/W2329398069"],"abstract_inverted_index":{"The":[0],"author":[1],"reviewed":[2],"the":[3,8,34,60],"relatively":[4],"poor":[5],"literature":[6],"on":[7,16,33,42],"topic":[9],"and":[10,36,51,70],"its":[11,79],"key":[12],"clinical":[13,83],"trial":[14],"reports":[15],"perazine,":[17],"a":[18,87,91],"classical":[19],"antipsychotic":[20],"most":[21],"frequently":[22],"prescribed":[23],"in":[24,82],"Poland":[25],"for":[26,29,110],"psychoses,":[27],"especially":[28],"schizophrenia.":[30],"Based":[31],"mainly":[32],"Leucht":[35],"Hartung's":[37],"metaanalysis":[38],"as":[39,41],"well":[40],"other":[43],"authors'":[44],"trials":[45],"with":[46],"broader":[47],"context":[48],"of":[49,65,96,105],"typical":[50],"atypical":[52,75,112],"neuroleptics":[53],"comparisons,":[54],"it":[55],"could":[56],"be":[57],"concluded":[58],"that":[59],"perazine":[61],"bearing":[62],"balanced":[63],"profile":[64],"psychotropic":[66],"action":[67],"(antipsychotic,":[68],"anti-autistic":[69],"sedative)":[71],"has":[72],"also":[73,90],"some":[74],"features":[76],"which":[77,98],"explain":[78],"broad":[80],"applications":[81],"practice.":[84],"Not":[85],"without":[86],"meaning":[88],"are":[89,99,115],"few":[92],"dozen-fold":[93],"lower":[94],"costs":[95,104],"treatment,":[97],"even":[100],"more":[101],"meaningful":[102],"when":[103],"necessary":[106],"laboratory":[107],"tests":[108],"required":[109],"monitoring":[111],"antipsychotics":[113],"use":[114],"taken":[116],"into":[117],"consideration.":[118]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
